HERON THERAPEUTICS, INC. /DE/ (HRTX)


Stock Price Forecast

April 19, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading HERON THERAPEUTICS, INC. /DE/ chart...

About the Company

We do not have any company description for HERON THERAPEUTICS, INC. /DE/ at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

283

Exchange

Nasdaq

$194M

Total Revenue

283

Employees

$397M

Market Capitalization

-2.79

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $HRTX News

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2023 Earnings Call Transcript

1mon ago, source: InvestingChannel on MSN

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2023 Earnings Call Transcript March 12, 2024 Heron Therapeutics, Inc. isn't one of ...

Commit To Buy Heron Therapeutics At $2, Earn 22.4% Annualized Using Options

9d ago, source: Nasdaq

Investors eyeing a purchase of Heron Therapeutics Inc (Symbol: HRTX) stock, but cautious about paying the going market price of $2.80/share, might benefit from considering selling puts among the ...

Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates

1mon ago, source: WATE 6 On Your Side

SAN DIEGO, March 12, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced financial results for the ...

Heron Therapeutics: Q4 Earnings Snapshot

1mon ago, source: Houston Chronicle

SAN DIEGO (AP) — SAN DIEGO (AP) — Heron Therapeutics Inc. (HRTX) on Tuesday reported a loss of $10.7 million in its fourth quarter. The San Diego-based company said it had a loss of 7 cents ...

Heron Therapeutics Inc HRTX

7d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Q4 2023 Heron Therapeutics Inc Earnings Call

1mon ago, source: Yahoo Finance

Kevin Warner; SVP of Medical Affairs strategy engagements; Heron Therapeutics Inc William Forbes; EVP, Chief Development Officer; Heron Therapeutics Inc Ira Duarte; Chief Financial Officer; Heron ...

Heron Therapeutics Inc HRTX

26d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...